1. Development of the Synthetic Route to PF-06878031 Part 1: Selective Alkylation Route
- Author
-
Brea, Oriana, Buck, Julia, Carson, Nessa, Derrick, Andrew M., Fussell, Steven J., Gymer, Adam E. S., Hawksworth, Michael, Hopkins, Adam W., Ingram, Heather, Johnson, Rebecca A., Laity, Daniel A., Mathew, Jinu S., Moses, Ian B., Rellegue, James, Rose, Emily K., Twiddle, Steven J. R., and West, Adam
- Abstract
The target compound PF-06878031is a key structural fragment of a range of oral late-stage glucagon-like peptide-1 receptor agonists (GLP-1-RA) under development in our laboratories for the indications of type-2 diabetes mellitus (T2DM) and weight loss. This article describes the identification of a selective alkylation route and development of a process, capable of delivering multikilo quantities of PF-06878031. Process development afforded improved safety, increased yield, reduced step count, and lowered PMI. The new process has been scaled up at multiple facilities to generate >1.5MT of high purity PF-06878031.
- Published
- 2024
- Full Text
- View/download PDF